Coronado Industries to Exhibit at Upcoming American Academy of Ophthalmology Meeting.Canadian Direct Sales Initiative a Key Component of This Year's Meeting FOUNTAIN HILLS, Ariz. -- Ophthalmic International (www.ophthalmicinternational.com), a wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. of Coronado Industries, (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). BB: CNDO CNDO Complete Neglect of Differential Overlap CNDO Congenital Nasolacrimal Duct Obstruction ) (www.coronadoindustries.com) today announced its plans for the upcoming American Academy of Ophthalmology The American Academy of Ophthalmology (AAO) is a medical association of ophthalmologists–medical doctors (MDs) specializing in eye care and surgery). The group is based in San Francisco, California. Meeting to be held November 10-14th in Las Vegas, Nevada. This meeting typically draws attendance from over 25,000 ophthalmologists and health care professionals from around the world. The focus of this year's meeting will be on sales of our Pneumatic Trabeculoplasty (PNT PNT Point PNT Paint (MacPaint graphic file format) PNT Patient PNT Pentagon (Washington, DC; US DoD) PNT Positioning, Navigation and Timing PNT Prime Number Theorem PNT Phenytoin ) equipment and rings to the eye care professionals in those countries where our products are approved, said Dr. John Sharkey, President of Ophthalmic International. Doctors routinely travel from other countries to this meeting with the express purpose of purchasing equipment not readily available in their own country. "With product approvals across Europe and now in Canada we need to increase our efforts to make physicians aware of the benefits of PNT to both them and their patients. Our message is that PNT is an innovative procedure for the management of open angle glaucoma glaucoma (glôkō`mə), ocular disorder characterized by pressure within the eyeball caused by an excessive amount of aqueous humor (the fluid substance filling the eyeball). and ocular hypertension and that it can easily be integrated into their practices and traditional treatment regimes." Mr. Richard Smith, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Coronado Industries, said he was excited about the opportunity to begin to initiate direct sales. "We routinely get inquires from physicians in countries where the product can be sold but we do not yet have distributors in place. We have put systems and procedures in place, driven primarily by our direct sales initiative in Canada which will allow us to also service these locations. We will be introducing this at the upcoming AAO AAO American Association of Orthodontists; American Academy of Ophthalmology; American Academy of Otolaryngology; American Academy of Osteopathy. AAO and we are excited about our prospects." Dr. Sharkey closed by reiterating how important the AAO is for companies such as Ophthalmic International. "At the AAO we have the opportunity to interface with a large number of ophthalmologists from around the world. These physicians also have the opportunity to interface with our investigators from Europe and hear first hand about the benefits of PNT. Finally, it offers us the opportunity to meet face to face with our current distributors and initiate discussions with potential new distributors. This is a very busy meeting for us and we are looking forward to participating in this year's meeting." Ophthalmic International, is focused on the development and commercialization of its patented procedure as a cost-effective alternative for the treatment of the most common types of glaucoma which are open angle and pigmentary as well as for the treatment of ocular hypertension. For more information about Coronado Industries, please visit our website at www.coronadoindustries.com or contact: Bob Smith Investor Relations < Victor Webb/Madlene Olson, Media Coronado Industries < Marston Webb International 1 (480) 837-6810 < 1 (212) 684-6601 Forward-looking statements in this release are made pursuant to the "safe harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. " provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, continued acceptance of the company's products, increased levels of competition for the company, new products and technological changes, the company's dependence on third-party suppliers, and other risks detailed from time to time in the company's periodic reports filed with the Securities and Exchange Commission. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion